ReviewThoracic cancer2018

Afatinib as first-line treatment for advanced lung adenocarcinoma patients harboring HER2 mutation: A case report and review of the literature.

Yuequan Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.